Abstract
9071Background: Patritumab (P) is a fully human anti-HER3 antibody that blocks activation by the ligand, heregulin (HRG), inducing receptor internalization. Preclinical study observed its efficacy ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
